| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Valuation Compression Pulls Down KLA (KLAC) Despite Raised Outlook | ||
| Mo | Applied Materials (AMAT) Slides Despite EPS Surge and Higher Analyst Estimates | ||
| Mo | GE Aerospace (GE) Falls Alongside Industrials | ||
| Mo | McKesson (MCK) Surged 13% Following Strong Q3 Results | ||
| Mo | Pulse Equity: Gix Internet's Autonomous Robots Take On Critical Hospital Logistics Roles at One of the World's Top Hospitals - Here's Why It Matters | ||
| Mo | Businesses Are Starting to Pay for AI Agents: 4 Stocks Building in the Space (CHGA, META, CRM, NOW) | ||
| So | CSX (CSX) vs. UNP and NSC: Can New Leadership Turn Efficiency Gains Into Lasting Growth? | ||
| So | Cintas (CTAS) vs. UNF and ARMK: Can Acquisition Synergies Unlock More Upside From a High-Quality Business? | ||
| Sa | 10 Best High Growth Stocks Outside Big Tech | ||
| Sa | 10 Best Biotech Stocks Under $10 to Buy | ||
| Sa | Here's Why Janus Henderson is Bullish On Meta Platforms, Inc. (META) | ||
| Sa | Advance Auto Parts (AAP) vs. ORLY and GPC: Can Its Operational Turnaround Unlock Significant Upside? | ||
| Sa | AnaptysBio (ANAB) vs. PTCT and MIRM: Is the Market Missing the Value of Its Royalty Stream and Legal Upside? | ||
| Sa | Cal-Maine Foods (CALM) vs. VITL and POST: Can Egg Price Recovery and Mean Reversion Unlock CALM's Undervalued Potential? | ||
| Sa | Core Scientific (CORZ) vs. CIFR and WULF: Can Its Shift From Bitcoin Mining to AI Colocation Unlock Long-Term Value? | ||
| Sa | Descartes Systems Group (DSGX) vs. SPSC and TRMB: Can Its Global Logistics Network Drive Sustainable Growth? | ||
| Sa | Billionaire Howard Marks' AI Warning and 10 Non-AI Stock Picks | ||
| Sa | Nordson (NDSN) vs. IEX and DOV: Can Semiconductor Expansion Turn Precision Manufacturing Into a Growth Story? | ||
| Sa | Ondas (ONDS) vs. AVAV and RCAT: Can Its Expanding Defense Platform Turn Backlog Growth Into Sustainable Profits? | ||
| Sa | Stock Market Movers: 30 October 2026 | ||
| Sa | Ultragenyx (RARE) vs. SRPT and BMRN: Can Upcoming Drug Approvals Unlock the Next Phase of Biotech Growth? | ||
| Fr | Velaris Markets offers simulated prop accounts up to $100,000 with an 80% split | ||
| Fr | Hedge Fund Investor Letters Q3 2026 | ||
| Fr | Operating Leverage and Financial Strength Anchor Champion Homes (SKY) Investment Thesis | ||
| Fr | Versigent (VGNT) is Unlocking Value Through Independent Growth and Capital Allocation |